Historic Move Could Transform Psilocybin Access for Terminally Ill Patients
The DEA requested that federal health officials conduct a medical review of psilocybin - a watershed moment for psychedelic medicine.
Read More
The DEA requested that federal health officials conduct a medical review of psilocybin - a watershed moment for psychedelic medicine.
Read More
The VA has confirmed an expansion of psychedelic assisted therapy trials for veterans with PTSD, treatment resistant depression, and anxiety.
Read More
Colorado regulators are reviewing rules that could add ibogaine to the state's Natural Medicine program -- making it the first
Read More
MDMA, psilocybin, and ketamine are transforming PTSD treatment. See the latest trial data, VA programs, state access, and what's available
Read More
The 5 best ketamine clinics in Kansas City (2026), verified for pioneer ketamine psychiatry, multimodal interventional stack, and pricing —
Read More
The 3 best ketamine clinics in Northern Colorado (2026), verified for KAP integration, multidisciplinary integrative-psychiatry team at Wholeness Center, and
Read More
Definium Therapeutics LSD based pill, DT120 ODT, reduced depression symptoms in a phase 3 trial of adults with major depressive
Read More
The national median price of a ketamine infusion in 2026 is $400. That number comes from our own directory. We
Read More
A new Canadian Journal of Psychiatry paper argues leaner psychedelic protocols displace integration work onto patients’ families. HealingMaps survey data
Read More
Most clinics market Spravato for treatment-resistant depression only. A second FDA indication covers acute suicidal ideation, and the ASPIRE trials
Read More